Integrated forecasting and supply chain planning platforms can close the gap between forecasting and execution by connecting forecasting data directly to inventory optimization and replenishment processes.

AstraZeneca selected supply chain planning software provider OMP to help redefine the biopharmaceutical giant's global planning capabilities.

Incisiv’s 2026 supply chain resilience report, conducted in partnership with Anaplan, assesses the current state of supply chain operations by surveying industry leaders across North America and EMEA. By examining strategic priorities, demand-supply responsiveness, technology and AI infrastructure, and financial outcomes, the research uncovers the critical financial impact of the “latency tax”— the hidden cost of delayed decision-making — and how to reclaim that margin.

Modern leaders need data-driven insights to make confident, real-time decisions that shield margins, enhance supply chain operations, and enrich customer experiences. As executives face a deluge of data points, this isn’t always straightforward. Global supply chain organizations face additional uncertainty — ranging from shifting environmental conditions to geopolitical disruption.

Procurement’s influence within the enterprise has expanded significantly over the past few years. The more important question now is how that influence translates into measurable outcomes.

As supply chains become more data-driven, the critical question is whether visibility reflects reality. 

The path forward is smarter architecture — fewer platforms, governed by the people who know the business best.

A new platform draws on the principles of genetics to supercharge inventory decisions across warehouse networks.

With active caching, inventory updates complete more quickly and efficiently, so that they can accurately reflect availability across locations in real time.

A look at how supply chains can bring together data, planning and execution, with Christine Barnhart, head of industry engagement with Miebach, and Andrew Driscoll, commercial lead-life sciences with OMP.